Page 303 - Tata_Chemicals_yearly-reports-2021-22

01 INTEGRATED 73 STATUTORY 178 FINANCIAL
STATEMENTS
REPORT
REPORTS
Consolidated

Note - ii
Alcad
₹ in crore
Year ended Year ended
Movement of Non-controlling interest
March 31, 2022 March 31, 2021
Opening carrying value as at April 1 - -
NCI’s share of profit for the year 65.74 67.44
Dividends received for the year (65.74) (67.44)
Closing carrying value as at March 31 - -

₹ in crore
Year ended Year ended
Summarised Statement of Profit and Loss
March 31, 2022 March 31, 2021
Revenue and other income 397.10 415.08
Cost of sales (265.63) (280.20)
Profit before tax 131.47 134.88
Income tax expense - -
Profit for the year 131.47 134.88
NCI’s share of profit for the year 65.74 67.44
Note - iii
PT Metahelix Lifesciences Indonesia
₹ in crore
As at As at
Particulars
March 31, 2022 March 31, 2021
Closing carrying value as at March 31 - 0.69
NCI’s share of profit for the year - -

301